Banque Cantonale Vaudoise Adaptive Biotechnologies Corp Transaction History

Banque Cantonale Vaudoise

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 17, 2022	SELL	$6.5 - $12.67 $4,550 - $8,869	-700 Reduced 70.0%	300 $2,000
Q2 2021 Aug 11, 2021	BUY	$32.22 - $44.59 $9,666 - $13,377	300 Added 42.86%	1,000 $41,000
Q1 2021 May 11, 2021	BUY	$37.26 - $67.74 $26,082 - $47,418	700 New	700 $28,000
Q3 2020 Oct 30, 2020	SELL	$35.79 - $48.81 $24,551 - $33,483	-686 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$24.95 - $48.38 $17,115 - $33,188	686 New	686 $33,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.